Search Results
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Daria Handkiewicz-Junak in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
radioiodine imaging and therapy in differentiated thyroid cancer . Endocrinology and Metabolism Clinics of North America 2017 46 783 – 793 . ( https://doi.org/10.1016/j.ecl.2017.04.007 ) 10 Pacini F Schlumberger M Harmer C Berg GG Cohen O Duntas
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Susanne Singer in
Google Scholar
PubMed
Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Search for other papers by Beate Bartes in
Google Scholar
PubMed
Search for other papers by Kate Farnell in
Google Scholar
PubMed
Department of Internal Medicine and Therapeutics, University of Pavia, Italy
Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
, Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy . Journal of Clinical Endocrinology and Metabolism 2006 91 2892 – 2899 . ( https://doi.org/10.1210/jc
Search for other papers by Carla Gambale in
Google Scholar
PubMed
Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Search for other papers by Lea Contartese in
Google Scholar
PubMed
Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Gabriele Materazzi in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Antonio Matrone in
Google Scholar
PubMed
cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan . Journal of Clinical Endocrinology and Metabolism 2010 95 1169 – 1173 . ( https://doi.org/10.1210/jc.2009-1567 ) 8 Ma C Kuang A & Xie J . Radioiodine therapy for
Search for other papers by Xian Qiu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
commonly achieved because of its indolent nature and adequate management strategies, including surgery, radioiodine ( 131 I) treatment, and levothyroxine therapy ( 2 ). However, persistent/recurrent or metastatic DTC, which is refractory to 131 I therapy
Search for other papers by Nianting Ju in
Google Scholar
PubMed
Search for other papers by Liying Hou in
Google Scholar
PubMed
Search for other papers by Hongjun Song in
Google Scholar
PubMed
Search for other papers by Zhongling Qiu in
Google Scholar
PubMed
Search for other papers by Yang Wang in
Google Scholar
PubMed
Search for other papers by Zhenkui Sun in
Google Scholar
PubMed
Search for other papers by Quanyong Luo in
Google Scholar
PubMed
Search for other papers by Chentian Shen in
Google Scholar
PubMed
have a good prognosis due to the biological behavior and standard treatments. Three conventional treatment regimens for thyroid cancer are surgery, radioiodine ( 131 I) therapy, and thyroid-stimulating hormone (TSH) suppression. Among them, 131 I is
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by James Nagarajah in
Google Scholar
PubMed
Search for other papers by Janneke E W Walraven in
Google Scholar
PubMed
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Search for other papers by Adriana C H van Engen-van Grunsven in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy . Journal of Clinical Endocrinology and Metabolism 2006 91 2892 – 2899 . ( https://doi.org/10.1210/jc.2005-2838 ) 5 Van
Search for other papers by Diana Borges Duarte in
Google Scholar
PubMed
Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed
Search for other papers by Guilherme Assunção in
Google Scholar
PubMed
Search for other papers by André Couto Carvalho in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
incidence of NTSPM in a series of patients with PTC at our institution. Secondary aims were to assess the relative risk for NTSPM in PTC patients and its potential associated factors, namely, radioiodine therapy exposure. Methods Study design A
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Junyu Tong in
Google Scholar
PubMed
Department of Nuclear Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
Search for other papers by Maomei Ruan in
Google Scholar
PubMed
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Hao Fu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Search for other papers by Qiong Luo in
Google Scholar
PubMed
Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Zhiyan Liu in
Google Scholar
PubMed
Search for other papers by Zhongwei Lv in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
, extrathyroidal invasion; LM, lymph node metastasis; NR, not reported; RT, radioiodine therapy; TKI, tyrosine kinase inhibitors; TT, total thyroidectomy. Surgery Total thyroidectomy with lymph node dissection is the first-line management for PDTC
FMTS, Université de Strasbourg, Faculté de Médecine, France
Search for other papers by Bernard Goichot in
Google Scholar
PubMed
Search for other papers by François Lefebvre in
Google Scholar
PubMed
Search for other papers by Stéphane Vinzio in
Google Scholar
PubMed
Search for other papers by Anne Cailleux in
Google Scholar
PubMed
Search for other papers by Jean-Marc Kuhn in
Google Scholar
PubMed
Search for other papers by Olivier Schneegans in
Google Scholar
PubMed
Search for other papers by Bodgan Catargi in
Google Scholar
PubMed
Search for other papers by Olivier Gilly in
Google Scholar
PubMed
Search for other papers by Philippe Baltzinger in
Google Scholar
PubMed
iCUBE, CNRS UMR, Illkrich, France
Search for other papers by Nicolas Meyer in
Google Scholar
PubMed
Université Paul Sabatier, Inserm, Toulouse, France
Search for other papers by Philippe Caron in
Google Scholar
PubMed
Search for other papers by the investigators of the Pirahtes study † in
Google Scholar
PubMed
trial designed to evaluate the effects of radio-iodine treatment on the risk of AF in patients with SCH. Materials and methods PIRAHTES ( P lace de l' I ode R adio A ctif dans l' H yper T hyroïdi E S ub-clinique/Evaluation of the interest of SCH
Search for other papers by Daniela Dias in
Google Scholar
PubMed
Search for other papers by Inês Damásio in
Google Scholar
PubMed
Search for other papers by Pedro Marques in
Google Scholar
PubMed
Search for other papers by Helder Simões in
Google Scholar
PubMed
Search for other papers by Ricardo Rodrigues in
Google Scholar
PubMed
Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Nova Medical School: Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy . Journal of Clinical Endocrinology and Metabolism 2006 91 2892 – 2899 . ( https://doi.org/10.1210/jc.2005-2838 ) 2 Nixon IJ Whitcher MM Palmer FL Tuttle RM Shaha AR